0

Cardiovascular and Metabolic Disease Center
Mitochondrial Research Affinity Collaboration-Laboratories & Engineering

Home > 0

Coenzyme Q10 and Exercise Training Benefit Patients With Chronic Heart Failure

  • 작성자한진
  • 작성일2007-01-11 01:12:08
  • 조회수1804
  • 첨부파일첨부파일
NEW YORK (Reuters Health) Dec 29 - Oral coenzyme Q10 improves functional capacity, endothelial function, and left ventricular contractility in patients with chronic heart failure, according to a study in the November issue of the European Heart Journal. "Coenzyme Q10 (CoQ10), first isolated from beef heart mitochondria, is an essential component of the mitochondrial respiratory chain, and also has antioxidant properties," Dr. Romualdo Belardinelli, of Lancisi Heart Institute, Italy, and colleagues write. "However, its role in chronic heart failure (CHF) is not well defined." The study included 23 patients (mean age 59 years) with NYHA class II or III CHF secondary to ischemic heart disease (ejection fraction 37%). Patients were assigned to 4 weeks each of the following: oral CoQ10 (100 mg tid), CoQ10 plus supervised ET, (60% of peak VO2, 5 times/wk), placebo, and placebo plus ET. Of the 23 patients, 21 completed the study. No side effects were attributed to CoQ10. Supplementation with CoQ10 led to a four-fold increase in plasma CoQ10 level (from 0.82 mcg/mL to 3.64 mcg/mL, p < 0.0001). A significant decrease in plasma levels of uric acid (-3%, p < 0.0001) and a significant increase in HDL (+3%, p = 0.0588) were observed with CoQ10 supplementation. No significant changes in total cholesterol. LDL-C, triglycerides, and vitamin E levels were observed. CoQ10 treatment significantly improved peak VO2 (+9%, p = 0.0001). "Systolic wall thickening score index (SWTI) had similar improvements as EF both at rest and at peak dobutamine (-9% and -12%, respectively; p < 0.0001)," Dr. Belardinelli's team writes. "These improvements were related to changes in regional contractility." Patients treated with CoQ10 had significant improvements in the endothelium-dependent relaxation (+38%, p = 0.0021). Combining ET with oral CoQ10 was linked to more marked improvements in all parameters. "Oral CoQ10 improves functional capacity, endothelial function, and left ventricular contractility in CHF without any side effects," the authors conclude. Eur Heart J 2006;27:2675-2681.
Total406 [ page14/28 ]
No. 제목 작성자 작성일 조회수
211 3D-ultrasound images of fetals 첨부파일 2006.12.01 dang van cuong 2006.12.01 1,882
210 Congratulation-Prof Han Jin (8) 2006.11.20 박원선 2006.11.20 2,222
209 Congratulation!! Cuong!! 전국과학사진공모전 입상 (3) 2006.10.24 한진 2006.10.24 2,326
208 줄기세포, 동물실험서 뇌종양 형성 2006.10.23 한진 2006.10.23 2,180
207 “체질맞춤형 의약품시대가 도래하고 있다” 2006.10.23 한진 2006.10.23 2,126
206 PGC-1 alpha implicated in Huntington's disease neurodegeneration 2006.10.22 한진 2006.10.22 5,091
205 2000년 이후 국내 연구자(제1저자 주소 기준) 생물정보학 논문분석(2006년 10월 13일 현재 기준) 2006.10.13 한진 2006.10.13 2,573
204 Heart signals give clues about potential drug toxicity 2006.10.12 한진 2006.10.12 4,990
203 항비만 식욕 억제 단백질 발견 (1) 2006.10.10 한진 2006.10.10 2,780
202 9월 생물정보학 분야 국내 연구자 논문 발표 실적 (1) 2006.10.10 한진 2006.10.10 2,517
201 Breakthrough offers new tool for studying degenerative disease 2006.10.10 한진 2006.10.10 4,823
200 Scientists Find Clue to Cell Suicides 2006.10.10 한진 2006.10.10 2,246
199 Identification of a mammalian mitochondrial porphyrin transporter 2006.10.10 한진 2006.10.10 2,603
198 Study identifies possible mechanism for brain damage in Huntington's disease 2006.10.10 한진 2006.10.10 2,386
197 The Nobel Prize in Physiology or Medicine 2006 (4)첨부파일 2006.10.04 한진 2006.10.04 2,415
처음 이전 11 12 13 14 15 16 17 18 19 20 다음 마지막